Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_30b3bcef1baf892352fc39693f0c1892 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
filingDate |
2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d8a9f7d03515c91e2f8fa300986fc12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3012657613683ed08dcb7eff822f01b6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073a1f3e1655ee827f0693580700c19f |
publicationDate |
2017-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2017149339-A1 |
titleOfInvention |
Non-bioconvertible c3-substituted pregnenolone derivatives for use in the treatment of treatment-resistant depression |
abstract |
The present invention relates to compounds of formula (I), which are blocked in C 3 position and cannot metabolize in vivo into pregnenolone derivatives and which do not have significant affinity for steroid hormonal receptors and for all tested classical main receptors and receptors of neurotransmitters of the central nervous system, for the treatment of treatment- resistant depression (TRD). |
priorityDate |
2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |